OncoLink at ASCO 1999: Monday, May 17


Combination Chemotherapy Regimen Yields Impressive Results in Late-Stage Prostate Cancer
PET Scans More Effective than Standard Technique at Accurately Staging Lung Cancer
Preliminary Results of High-Dose Chemotherapy in Primary Breast Cancer Show Equivalency to Intermediate-Dose Treatment; 3 Years of Additional Follow-up Required
Scandinavian Study Finds No Overall Survival Benefit to High-Dose Chemotherapy in Primary Breast Cancer
South African Study Finds Survival Benefit to High-Dose Chemotherapy in Primary Breast Cancer
Soy Remedy Not Effective for Hot Flashes with Breast Cancer
Stem Cells May be Engineered to Resist Toxic Effects of Chemotherapy
Study of High-Dose Chemotherapy in Metastatic Breast Cancer Finds No Survival Benefit

News
ASCO: Option to Skip Surgery Viable for Some With Rectal CA

Jan 14, 2015 - Some rectal cancer patients may fare just as well by forgoing surgery in favor of chemotherapy/radiation and "watchful waiting," according to research presented Monday at the American Society of Clinical Oncology's annual Gastrointestinal Cancers Symposium, held from Jan. 15 to 17 in San Francisco.



I Wish You Knew

How cancer patients have changed my life

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More